Turning to Broad Sequencing Panels for Targeted Therapy in Advanced NSCLC

10:55 EDT 26 Jul 2019 | OncLive

Mohammad Razaq, MD, discusses how the detection of driver mutations has changed the way treatment is approached in advanced non–small cell lung cancer.

More From BioPortfolio on "Turning to Broad Sequencing Panels for Targeted Therapy in Advanced NSCLC"